Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
Clinical trial NCT03735225 · COMPLETED
Trial details
- NCT number
- NCT03735225
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2019-06-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.